RyboDyn
Decrypting the dark proteome
- Headquarters
- San Diego
- Employees
- 1–10
- Founded
- 2022
- Website
- rybodyn.com
- Total Funding
- $4.0M
- Last Round
- $4.0M Pre-SeedJan 2025
About
RyboDyn is a biotechnology company pioneering immunotherapy development by unlocking the dark proteome through its proprietary RyboCypher™ platform, which fuses novel RNA sequencing with AI models to predict proteins encoded by non-coding RNAs. The company transforms these hidden Cryptic Targets™ into antibody-based drug candidates for next-generation cancer immunotherapies.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account